FDA Issues Warning for Topical Analgesics with High Levels of Lidocaine
Revising the CDC Clinical Guideline for Prescribing Opioids
Opioid Usage Increasing in Patients with Fibromyalgia in Recent Years
Alan Kaye, MD, PhD: Treating Pain Traditionally and with Alternate Therapies
VX-548 Significantly Reduces Moderate to Severe Acute Pain, Phase III Program Data Reveal
FDA Expands Bupivacaine and Meloxicam (Zynrelef) Approval to Include Additional Orthopedic and Soft Tissue Procedures
